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Abstract
Background: Many inherited polyneuropathies (PN) observed in dogs have clinical similarities to the genetically
heterogeneous group of Charcot-Marie-Tooth (CMT) peripheral neuropathies in humans. The canine disorders
collectively show a variable expression of progressive clinical signs and ages of onset, and different breed prevalences.
Previously in the Leonberger breed, a variant highly associated with a juvenile-onset PN was identified in the canine
orthologue of a CMT-associated gene. As this deletion in ARHGEF10 (termed LPN1) does not explain all cases, PN in this
breed may encompass variants in several genes with similar clinical and histopathological features.
Results: A genome-wide comparison of 173 k SNP genotypes of 176 cases, excluding dogs homozygous for the
ARHGEF10 variant, and 138 controls, was carried out to detect further PN-associated variants. A single suggestive
significant association signal on CFA15 was found. The genome of a PN-affected Leonberger homozygous for the
associated haplotype was sequenced and variants in the 7.7 Mb sized critical interval were identified. These variants
were filtered against a database of variants observed in 202 genomes of various dog breeds and 3 wolves, and 6
private variants in protein-coding genes, all in complete linkage disequilibrium, plus 92 non-coding variants were
revealed. Five of the coding variants were predicted to have low or moderate effect on the encoded protein, whereas
a 2 bp deletion in GJA9 results in a frameshift of high impact. GJA9 encodes connexin 59, a connexin gap junction
family protein, and belongs to a group of CMT-associated genes that have emerged as important components of
peripheral myelinated nerve fibers. The association between the GJA9 variant and PN was confirmed in an
independent cohort of 296 cases and 312 controls. Population studies showed a dominant mode of inheritance, an
average age of onset of approximately 6 years, and incomplete penetrance.
Conclusions: This GJA9 variant represents a highly probable candidate variant for another form of PN in Leonberger
dogs, which we have designated LPN2, and a new candidate gene for CMT disease. To date, approximately every third
PN-diagnosed Leonberger dog can be explained by the ARHGEF10 or GJA9 variants, and we assume that additional
genetic heterogeneity in this condition exists in the breed.
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Background
Several studies have reported the occurrence of peripheral
neuropathies (PN) in many breeds of dogs [1–4]. Affected
dogs present with abnormal motor signs including
weakness, hypotonia and muscle atrophy secondary to
denervation [1]. Focal signs such as laryngeal paralysis, a
change in the pitch of the bark, inspiratory stridor, and
dyspnea, can be the only clinical abnormalities early in the
progressive course of the disease and are considered as
strong indicators of the presence of an underlying neur-
opathy that may later progress [1–3]. An observational
study across breeds revealed that approximately every
second dog with laryngeal paralysis had evidence of diffuse
PN [3].
The histopathological phenotype seen in many canine
PNs is similar to the most common group of inherited
polyneuropathies in humans, known as Charcot-Marie-
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Tooth (CMT) disease [5]. Nearly 30 years ago it was
already speculated that some forms of canine PN repre-
sent inherited diseases [2]. This was recently confirmed
by unraveling causative recessive variants in the canine
orthologue of a human CMT-associated gene (NDRG1)
in Greyhounds [6] and Alaskan Malamute dogs [7] with
early-onset PN (OMIA 001292–9615). More recently,
RAB3GAP1-associated forms of syndromic PN accom-
panied by ocular abnormalities and neuronal vacuolation
(OMIA 001970–9615) were described independently in
Black Russian Terriers [8], Rottweilers [9] and Alaskan
Husky dogs [10].
The Leonberger breed was formed by the crossing of
several large-bodied breeds, including Saint Bernards,
Newfoundlands, and Great Pyrenees. Chronic nerve
fiber loss associated with axonal degeneration, decreased
myelinated fiber density and a shift of the axonal size-
frequency distribution toward smaller fibers is the pre-
dominant finding in peripheral nerves of PN-affected
Leonberger dogs [1, 5]. PN in Leonbergers is twice as
frequent in males as females, has a wide age range of on-
set, and due to the absence of pain and gradual onset of
clinical signs, may go undetected for a number of
months to years. An ARHGEF10 loss-of-function 10 bp
deletion, affecting another human CMT-associated can-
didate gene, was shown to be highly associated with a
severe juvenile-onset form of PN in Leonberger, as well
as Saint Bernard dogs (OMIA 001917–9615) [11]. In a
cohort of more than 200 affected Leonberger dogs ap-
proximately 80% of all PN cases were found to be nega-
tive for the mutant ARHGEF10 allele [11], suggesting
that PN in this breed may be a result of several genetic-
ally distinct variants having similar clinical and histo-
pathological features. The goal of the present study was
to identify additional disease-associated variants for PN
in Leonberger dogs using a positional cloning strategy.
Methods
Animals
Genomic DNA was isolated from blood using either the
Gentra PureGene blood kit (Qiagen) or the Maxwell
RSC whole blood DNA kit (Promega). All dogs were
genotyped for an ARHGEF10 deletion (i.e., the LPN1
allele) as previously described [11], and only dogs that
were homozygous wild type or heterozygous for the
ARHGEF10 allele were selected for genotyping on the
SNP arrays. The phenotypic characterization of PN in
Leonberger dogs has been described elsewhere [5] and
the previously established criteria to select cases and
controls were applied [11]. Samples from a total of 7455
Leonbergers, including 922 dogs with detailed phenotype
records (Additional file 1) were used during this study.
Initially, a cohort of 314 dogs was used for the GWAS;
later a follow-up cohort of 608 dogs with detailed
phenotype information was collected, in addition to
6533 dogs that were submitted without known pheno-
type status. A total of 56 PN-affected Leonberger dogs
homozygous for the deletion in ARHGEF10 were
excluded from the mapping studies.
Histopathology
As part of a larger study, diagnostic peroneal nerve biop-
sies collected under general anesthesia or peroneal nerve
samples collected at necropsy were immersed into 10%
neutral buffered formalin, resin embedded and cut into
thick (1 μm) sections for evaluation by a single patholo-
gist (GDS).
Genome analyses
A total of 314 dogs (176 cases and 138 controls;
Additional file 1), were genotyped on the Illumina
CanineHD BeadChip (Illumina, San Diego, CA, USA)
that contains 173,677 SNP markers. PLINK software
[12] was used to prune the genotyping data: (1) to re-
move SNPs with more than 10% missing genotype calls
per marker; (2) to exclude uninformative SNPs with a
minor allele frequency below 5%; and (3) to exclude
SNPs which exceed the Hardy-Weinberg disequilibrium
p-value of 0.0001. Population stratification, resulting
from close familial relationships, was confirmed by the
genomic inflation factor of 1.55 calculated during an
association test. Therefore, a mixed model approach
utilizing the GenABEL package [13] was applied for the
association analysis to correct for this population stratifi-
cation and any cryptic relatedness. This correction re-
sulted in a genomic inflation factor of 1.04. Haplotypes
around the significantly associated locus were con-
structed using fastPHASE [14]. All genome positions
refer to the CanFam3.1 reference sequence assembly.
Whole genome sequencing and variant calling
Whole genome sequence data at 12× coverage was
obtained from a PN-affected Leonberger dog after
preparation of a fragment library with a 250 bp insert
size and collection of 293,912,640 paired-end reads
(2 × 100 bp) using a HiSeq2500 instrument (Illumina).
The sequence data analysis and variant calling was per-
formed as described before [15]. The annotation version
CanFam3.1.75 (http://www.ensembl.org) was used to
predict the functional effects of detected variants as
described previously [15]. The genome sequencing data
were deposited in the European Nucleotide Archive
(ENA, http://www.ebi.ac.uk/ena) under sample accession
number SAMEA47266168 within study accession
PRJEB16012. The sequence data from the Leonberger
case were compared to the Boxer reference genome
(CanFam3) and 202 publically available control dogs of
66 various different breeds (Airedale Terrier, Alaskan
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Husky, Alaskan Malamute, Alpine Dachsbracke, American
Staffordshire Terrier, Australian Cattle dog, Australian
Shepherd, Australian Terrier, Basenji, Basset, Bavarian
Hound, Beagle, Bearded Collie, Berger Blanc Suisse, Border
Collie, Bull Terrier, Bullmastiff, Cairn Terrier, Cavalier King
Charles Spaniel, Chihuahua, Chinese indigenous dog,
Chow Chow, Cocker Spaniel, Curly Coated Retriever,
Dachshund, Doberman Pinscher, Elo, Entlebucher
Sennenhund, Eurasier, French Bulldog, German Shepherd,
German Spitz, German Wirehaired Pointer, Golden
Retriever, Great Dane, Greater Swiss Mountain Dog,
Greyhound, Heideterrier, Hovawart, Irish Terrier, Jack
Russell Terrier, Jagdterrier, Kromfohrländer, Kunming Dog,
Labrador Retriever, Lagotto Romagnolo, Landseer,
Leonberger, Malinois, Miniature Bull Terrier, Norwich
Terrier, Old English Sheepdog, Perro de Agua Español,
Pomeranian, Poodle, Rhodesian Ridgeback, Rottweiler,
Saluki, Shetland Sheepdog, Siberian Husky, Sloughi,
Tibetan Mastiff, Weimaraner, West Highland White
Terrier, Whippet, and Yorkshire Terrier) and 3 wolves;
deposited in the European Nucleotide Archive (http://
www.ebi.ac.uk/ena) under study accession numbers
PRJEB10823, PRJEB13139, PRJEB13468, PRJEB13723,
PRJEB14110, PRJEB14840, PRJEB16012, PRJEB4544,
PRJEB5500, PRJEB5874, PRJEB5875, PRJEB6076,
PRJEB6079, PRJEB7734, PRJEB7735, PRJEB7736,
PRJEB7903, PRJEB9437, PRJEB9590, PRJEB9591, and
PRJNA266585.
Additional genotyping
Sanger sequencing was used to confirm the Illumina
sequencing results and to perform targeted genotyping
for 6 variants identified from whole genome sequencing.
For these experiments we amplified PCR products using
AmpliTaqGold360Mastermix (Life Technologies) and
purified PCR products were directly sequenced on an
ABI3730 capillary sequencer (Life Technologies). The
sequence data were analyzed using Sequencher 5.1 soft-
ware (GeneCodes).
The GJA9 deletion was genotyped by fragment size
analysis (primers: CCTGACAACCACAGTGGAAA
(forward) and AGAGCAGTGGTTCCTTTTGC (reverse))
on an ABI3730 capillary sequencer and analyzed with the
GeneMapper 4.0 software (Life Technologies).
Comparison of GJA9 allele and genotype frequencies
in PN cases and controls was performed in the original
GWAS cohort, as well as an independent cohort, by
standard chi-square tests.
Results
GWAS mapping of a PN associated locus on CFA15
After pruning for low genotyping rate, low minor
allele frequency, and failure to meet Hardy-Weinberg
equilibrium, 108,801 SNPs remained for the association
analysis. A suggestive significant association signal on
CFA15 was identified, with the two most significant SNPs
(BICF2G630442965, at bp position 12,345,641; and
BICF2G630442606 at bp position 12,765,329) achieving a
corrected p-value of 1.97 × 10−6 (Fig. 1a; Additional
file 2). The quantile-quantile plot of observed versus
expected p-values of this mixed model analysis also
supports the effectiveness of the correction for popu-
lation structure and the significance of the CFA15
locus (Fig. 1b).
Haplotype reconstruction revealed evidence for an ap-
proximately 23 Mb sized disease-associated haplotype at
the centromeric end of acrocentric CFA15 (Additional
file 3). Five PN-affected dogs were homozygous for this
haplotype spanning from bp position 0 to 22,723,949
and 37 other cases were identified as heterozygous car-
riers of a single copy of the identical 22.7 Mb sized
haplotype. Further, 8 PN-affected dogs carried shorter
versions of this haplotype due to recombination events,
which enabled narrowing of the critical region to ap-
proximately 7.7 Mb (bp position 1,762,076 to 9,441,628)
(Additional file 3). This region contains 135 annotated
protein-encoding genes and 72 other loci.
Whole genome sequence analysis identifies a frameshift
variant in the GJA9 gene
Whole genome sequence was generated from a PN-
affected Leonberger homozygous for the associated
CFA15 haplotype and variants in the critical interval
were identified. We hypothesized that the causative
variant should be absent from breeds unrelated to the
Leonbergers, as pedigree analysis and the large size of
the associated haplotype clearly indicated a relatively
young origin of the mutation. A total of 98 variants in
the interval unique to the sequenced case remained after
filtering against 202 control genomes of 66 different dog
breeds and 3 wolves (Additional file 4). This represented
92 homozygous private non-coding variants as well as 6
coding variants, namely: synonymous variants in AGO3,
CSMD2 and GRIK3; missense variants in MYCL and
MACF1 that correspond to the reference alleles in other
species, and a 2 bp deletion causing a frameshift in GJA9
(Additional file 4). All 6 coding variants were genotyped
by Sanger sequencing and found to be in complete link-
age disequilibrium in a cohort of 96 Leonberger dogs, of
which 5 dogs were homozygous and 91 heterozygous for
the GJA9 variant.
The GJA9 gene was pursued as the most plausible
positional candidate gene due to its membership in the
connexin gene family known to be causative for human
CMT. The identified 2 bp deletion results in a prema-
ture stop codon at amino acid residue 382 of the 514
residue full length protein (Fig. 2). Specifically, the GJA9
variant (CanFam3.1: chr15.3863,524_3863,525delAG) results
Becker et al. BMC Genomics  (2017) 18:662 Page 3 of 9
in a frameshift (ENSCAFT00000038555: c.1107_1108delAG)
and premature stop codon (F1PSG8_CANLF:
p.Glu370AsnfsTer12) that is predicted to truncate
almost half of the intracellular C-terminus of the
encoded connexin. Thus we concluded that the GJA9
deletion is much more likely to cause PN than the
other 5 variants.
LPN2: A dominant inherited form of PN with incomplete
penetrance
To investigate the segregation and frequency of the
GJA9 variant, we genotyped in total 7455 Leonberger
dogs (Table 1). This includes all 314 Leonberger dogs
from the original GWAS cohort, a follow-up cohort of
608 dogs with detailed phenotype records available
(Additional file 1), and 6533 mostly young Leonbergers
with unknown phenotype status that were submitted for
diagnostic purposes, which represent the global popula-
tion of the breed. There was a highly significant difference
in GJA9 allele frequencies between PN cases and controls
from the original GWAS cohort (p < 5.5 × 10−8), reflected
in a difference in genotype frequencies under a dominant
model (p < 1.2 × 10−7), but not a recessive model
(p < 0.05) (Table 1). These figures give only borderline
support for a recessive hypothesis and make it much less
well supported than a dominant hypothesis. This result
was replicated in the follow-up cohort (genotype
frequency different at p < 1.9 × 10−7, genotype frequency
different in a dominant model at p < 1.7 × 10−7, but not a
recessive model at p < 0.15) (Table 1). The allele frequency
difference in these combined cohorts was significant
at p < 2.8 × 10−14 and the genotype frequency
difference under the dominant model was significant at
p < 6.8 × 10−14, clearly indicating dominant inheritance.
We then analyzed 137 dogs that carried at least one
copy of the GJA9 mutant allele to determine age of onset
and penetrance of the mutant allele (Additional file 1).
The owner-reported mean average age of onset in 100
dogs that showed clinical signs was 6 years, and varied
from 1 to 10 years (Fig. 3). Due to the limited number of
GJA9 homozygous mutant PN-affected dogs it was not
possible to assess whether heterozygous or homozygous
PN cases developed clinical signs at different stages in
life. Both homozygous mutant and heterozygous dogs of
both sexes developed PN, again consistent with an auto-
somal dominant pattern of inheritance. By 8 years of age
84 of the 137 (61%) dogs carrying the mutant allele
showed signs of PN, and within their lifetime 110 of the
137 (80%) showed signs, indicative of a reduced pene-
trance (Additional file 1). Lastly, the frequency of the
GJA9 variant in the global population of Leonbergers
was estimated as 0.032 (Table 1).
A total of 528 Leonbergers in our sample database
were diagnosed with PN when the 56 additional PN-
affected dogs homozygous for the deletion in ARH-
GEF10 were included. Thus, the disease phenotype of
approximately 11% (56/528) of all PN-affected Leonber-
gers could be explained by homozygosity for the ARH-
GEF10 (LPN1) variant, whereas homozygosity or
heterozygosity for the herein presented PN-associated
variant in the GJA9 gene, which we now term LPN2,
explains 21% (110/528) of all cases. Of the remaining
362 PN cases, 85 are LPN1 heterozygous and 277 PN-
affected dogs (52%) do not carry either known variant
(Additional file 1). Because it is still unclear whether
Fig. 1 Genome-wide association study for polyneuropathy in Leonberger dogs. a Note the association signal on chromosome 15. b The
quantile–quantile (QQ) plot shows the observed vs. expected log P-values. The straight line in the QQ plot indicates the distribution of SNP
markers under the null hypothesis, and the skew at the right edge indicates those markers that are more strongly associated with the trait than
would be expected by chance. Markers from chromosome 15 are shown in red
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having one copy of the LPN1 allele is sufficient to cause
disease, we examined the LPN1 allele frequency in
remaining cases (0.12) compared to controls (0.07). This
provides evidence of some additional genotypic risk as-
sociated with the possession of a single copy of the
ARHGEF10 variant, albeit at a level below 2. Altogether,
these allele frequencies continue to present ambiguity
(p = 6.7 × 10−4) in interpreting the correct mode of
inheritance of the LPN1 allele (Additional file 1).
Indistinguishable histopathology in PN affected
Leonberger dogs
Resin sections from the peroneal nerve were qualita-
tively evaluated from 5 Leonberger dogs with PN and
Fig. 2 A GJA9 frameshift variant in polyneuropathy affected Leonberger dogs. a IGV screenshots showing the homozygous presence of the 2 bp
deletion in the GJA9 gene on CFA15 in reads from the sequenced case (marked by a red arrow) compared to a control dog genome. b The
schematic representation indicates that the 2 bp deletion leads to a frameshift that is predicted to produce a significantly truncated intracellular
C-terminus of canine GJA9. Note that the transmembranal N-terminal connexin domain that is important for gap junction formation is predicted
to be unaffected
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the GJA9 variant (LPN2 heterozygous) and were com-
pared to Leonberger dogs with PN and the ARHGEF10
variant (LPN1 homozygous). None of the sections
evaluated were from dogs positive for both the GJA9
and ARHGEF10 variants. The prominent pathologic
abnormality was variably severe nerve fiber loss resulting
from chronic axonal degeneration (Fig. 4). Large nerve
fiber loss was most prominent with an increased popula-
tion of small caliber nerve fibers. Similar changes were
present in all nerves regardless of the genetic variant.
Discussion
Inherited canine PN has clinical similarities to the
genetically heterogeneous CMT peripheral neuropa-
thies in people. PN in the Leonberger breed shows a
variable expression of clinical signs and different ages
of onset from <1 year up to 10 years of age. The pre-
viously identified ARHGEF10 frame shift deletion
(termed LPN1) causes a severe early-onset disease
[11]. Initially, the LPN1 variant explained over 20% of
cases; however, due to widespread adoption of genetic
testing by breeders, we have not observed a LPN1
case born since 2011. Consequently, the proportion of
PN cases explained by the LPN1 mutation has
dropped precipitously; currently it explains only
approximately 11% of PN cases. Here, our search to
identify additional PN genes employed a GWAS with
176 PN affected Leonbergers, which were not homozy-
gous carriers of the recessive ARHGEF10 loss-of-function
variant, and 138 controls. Our present finding of the GJA9
variant strongly suggests a causative allele for a second
inherited form of PN (LPN2), with a wider range of ages
of onset and clinical severity, which explains an additional
21% of PN in this breed. These results further confirm
genetic similarities between Mendelian forms of PN in
dogs and humans. The characteristic axonal degeneration
and nerve fiber loss affecting long, large diameter nerves
in PN-affected Leonberger dogs resembled mixed forms
of human CMT [5]. While qualitative evaluation of
peripheral nerve histopathology can confirm the presence
of chronic axonal degeneration, nerves can only re-
spond in a limited number of ways to insult of any
type and may not be of value in distinguishing LPN
variants in Leonberger dogs. Quantitative studies are
in progress. The identification of the ARHGEF10
variant finally confirmed the previously assumed
Table 1 GJA9 c.1103_1104delAG genotype frequencies in three Leonberger cohorts
Polyneuropathy status Total wt/wt (homozygous normal; N/N) wt/del (heterozygous; D/N) del/del (homozygous mutant; D/D)
GWAS cohort 314 0.82 (258) 0.16 (51) 0.02 (5)
Affecteda 176 0.72 (127) 0.25 (44) 0.03 (5)
Non-affecteda,b 138 0.95 (131) 0.05 (7) 0
Follow-up cohort 608 0.87 (527) 0.13 (79) 0.003 (2)
Affecteda 296 0.79 (235) 0.20 (59) 0.006 (2)
Non-affecteda,b 312 0.94 (292) 0.06 (20) 0
Total 7455 0.94 (6995) 0.06 (443) 0.002 (17)
Affecteda 474 0.76 (362) 0.22 (105) 0.02 (7)
Non-affecteda,b 450 0.94 (423) 0.06 (27) 0
Unknownc 6533 0.95 (6210) 0.05 (313) 0.002 (10)
aOnly dogs that were homozygous wild type or heterozygous ARHGEF10 carriers
bOnly dogs ≥8 years old that showed no signs of PN
cDogs without known phenotype status that were submitted for diagnostic purposes
Fig. 3 Age of onset of clinical signs in dogs homozygous or
heterozygous for the GJA9 mutation. Age-of-onset of clinical signs
for the 100 PN cases in which one or two mutant GJA9 alleles
were present
Becker et al. BMC Genomics  (2017) 18:662 Page 6 of 9
similar pathogenesis of PN in Leonberger dogs to
CMT disease in people.
The herein identified 7.7 Mb-sized disease-associated
haplotype contained a total of 98 private variants. All 6
private coding variants were experimentally confirmed
to occur in complete linkage disequilibrium, the add-
itional 92 non-coding variants were not analyzed further,
because the frameshift variant in GJA9 affects a putative
candidate gene, and the variants in MYCL and MACF1
can most likely be ruled out by non-conservation. GJA9
encodes connexin 59, a connexin gap junction family
protein, whose members have emerged as important
components of peripheral myelinated nerve fibers. A
total of 21 human connexin genes are identified (20 in
the mouse), which can be classified into 5 groups based
on sequence homology [16]. Six connexin subunits
oligomerize to form a hemichannel (also known as
connexon) and hemichannels from two adjacent cells
dock together at their extracellular domains to form a
functional gap junction channel that mediates direct
intercellular communication in many physiological
processes [16]. Cells and tissues commonly express more
than one type of connexin, enabling the formation of
homomeric and heteromeric gap junctions [17], and
junctional communication between different cells often
requires such heterotypic gap junctions [16].
Diverse genetic diseases in humans, including disor-
ders of the nervous system, are caused by variants in
connexin genes [18]. The GJB1 gene, with more than
400 known variants, is causally implicated in one of the
five most common CMT subtypes in people [OMIM
304040; 19,20]. The encoded connexin 32 forms gap
junctions between the folds of Schwann cell membranes.
These Schwann cells wrap around the axons of periph-
eral nerves and form a layer of myelin that is critical for
the conduction of nerve impulses. Mutations in GJB1
appear to hinder diffusion across the concentric layers of
myelin, resulting in disruption of myelin and hence
axonal degeneration [19, 20]. Due to the male sex bias,
similar phenotype, and the slowly progressive nature of
the PN disease in Leonberger dogs, it was initially specu-
lated, that variants in the canine ortholog of GJB1
encoding connexin 32 could be responsible [21]. Our
identification of a variant in the related gap junction
protein GJA9 nicely confirms these earlier assumptions.
Interestingly, as we have observed in our canine study,
there is a high phenotypic variability within CMT geno-
types and variant-specific manifestations between differ-
ent human CMT types [22]. Recently, the human GJA9
gene, among others, was reported as novel candidate
disease gene for neurogenetic disorders after the first re-
sults from clinical exome sequencing of 149 patients
with various neurocognitive phenotypes [23]. But, to our
knowledge, there is as yet no non-synonymous GJA9
variant known to be associated with CMT in people.
Therefore this canine GJA9 associated form of PN pro-
vides an interesting animal model and adds this gene to
the list of candidates for human CMT. This is especially
of value as there is no GJA9 ortholog in the mouse gen-
ome [24]. Finally, in the light of the current status of the
dog reference genome and its incomplete annotation, we
acknowledge that the list of private variants of the
disease-associated haplotype is most likely not complete.
In addition to the fact that we were not able to exclude
the reported 97 private variants other than the GJA9
frameshift variant, one could assume that other un-
detected variants located in existing reference sequence
gaps or unrecognized structural variants exist on the
disease-associated haplotype.
The age-of-onset analysis indicates that LPN2 is a
dominantly inherited trait with incomplete penetrance.
Several heterozygous dogs >8 years of age still have not
shown clinical signs of weakness. This might suggest
that nerve cells can still function reasonably well with a
single copy of the normal allele, or even the absence of
the GJA9 protein entirely. The predicted protein from
Fig. 4 Representative histopathology of the peroneal nerve from
male Leonberger dog with polyneuropathy and heterozygous
GJA9 genotype. Resin embedded peroneal nerve sections
collected post-mortem from a 5 year old male intact Leonberger
dog with clinical signs of polyneuropathy. a Toluidine blue-acid
fuchsin stain showing loss of predominantly large myelinated
fibers and qualitatively increased populations of small calibre
nerve fibers. b Paraphenelenediamine stain for myelin showing
thin but intact myelin sheaths in many small nerve fibers. For
comparison, images (c, toluidine blue-acid fuchsin stain) and
(d, paraphenelenediamine stain) are from the peroneal nerve of
a 6 year old female neutered Leonberger dog that was negative
for both the ARHGEF10 and GJA9 variants and without clinical
signs of polyneuropathy
Becker et al. BMC Genomics  (2017) 18:662 Page 7 of 9
the mutant allele contains <75% of the amino acids
present in the wild type protein. It is possible that since
the four N-terminal transmembrane domains forming the
connexin channel domain are unchanged, the identified
variant with its significantly shortened intracellular C-
terminus may not be a complete loss-of-function allele.
Other mechanisms to explain the somewhat complex
genotype-age of onset-phenotype relationship include the
possibilities that other connexins partially serve the func-
tion of GJA9, a dominant-negative effect of the mutant
protein, or simple haploinsufficiency affected by genetic
background. We further suggest that the incomplete asso-
ciation between GJA9 genotype and PN in our large popu-
lation is partly due to contributions from phenocopies,
misdiagnoses, as well as genetic heterogeneity.
These findings have serious implications for breeders, as
genetically susceptible dogs may not develop clinical dis-
ease until later in life, if at all, and often well after a dog
may have bred multiple times. Since the offering of the
LPN2 test to the Leonberger community nearly 7500 dogs
have been genotyped for the GJA9 deletion. Although this
is not a random sample of the breed, the finding of a
mutant allele frequency of approximately 0.03, and its
dominant nature, indicates it should be considered a
serious problem for the health and welfare of breed.
Conclusions
Highly probable causative variants in the ARHGEF10 and
GJA9 genes have now been identified for two forms of PN
in Leonberger dogs. PN in this breed exhibits remarkable
variation in phenotypic severity and age of onset among af-
fected dogs, suggesting the influence of modifiers of both
the GJA9 form and additional forms not explained by either
known variant. It is likely that many more Leonberger dogs
with PN will be needed to improve the power to detect loci
that contribute to the non-ARHGEF10 /GJA9 form(s) of PN
in Leonbergers, which might represent a multigenic com-
plex trait. Characterization of genomic variation underlying
PN phenotypic variation in this breed with small effective
population size will present a powerful resource for under-
standing the molecular causes behind variable canine poly-
neuropathy phenotypes. Finally, this study adds GJA9 for
the first time to the list of candidate genes for human CMT.
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